Peptide CDMO 2.0 Market, Share & Trends Analysis Report, By Product Type / Modality (Linear Peptides, Cyclic Peptides, Stapled Peptides, Peptide–Drug Conjugates (PDCs), Peptide–Oligonucleotide Conjugates, GLP-1 and Related Long-Acting Analogues, Oral Peptide Formulations), By Scale of Operation (Preclinical, Clinical (Phase I–III), Commercial), By Business Model, By Technology, By Therapeutic Area, By End User By Region, and Segment Forecasts, 2025-2034